基于与谷氨酸触媒相关的酶的系统分析确定了GPT2作为肺腺癌的新型免疫治疗点

Bolin Wang1, Jinli Pei2, Shengnan Xu2

  • 1Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, China; Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences Jinan, Shandong, China; Research Unit of Radiation Oncology, Chinese Academy of Medical Sciences, Jinan, Shandong, China.

PubMed
概括

向谷氨胺代谢,特别是GPT2,对肺腺癌 (LUAD) 治疗有希望. 抑制GPT2抑制瘤生长并增强抗瘤免疫力,为LUAD提供了一种新的治疗策略.